...
首页> 外文期刊>Life sciences >Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: A possible direct effect of nicotine
【24h】

Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: A possible direct effect of nicotine

机译:健康吸烟者和非吸烟者单核细胞/巨噬细胞中PPAR-γ蛋白的定量:尼古丁的可能直接作用

获取原文
获取原文并翻译 | 示例

摘要

Previous observations demonstrated that Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ), a key regulator of adipocyte differentiation, is expressed in a large variety of cells, including cells of the monocyte/macrophage lineage. This study was aimed to quantify both the constitutive and ligand-induced PPAR-γ expression in monocytes and monocyte-derived macrophages (MDM) isolated from healthy smokers and non-smokers, and to evaluate the possible direct effect of nicotine. PPAR- γ protein was detected by Western blot and quantification was performed by calculating the ratio between PPAR-γ and β-actin protein expression. Cytokine release was measured with enzyme-linked immunoassay kits. Constitutive PPAR-γ protein was detected in human monocytes and its expression was up-regulated along with differentiation to MDM. The endogenous ligand 15-deoxy-delta12,14-prostaglandin J2 and the synthetic agonist ciglitazone enhanced PPAR-γ expression, the former being effective also at low micromolar concentrations. Both agonists significantly inhibited the basal secretion of pro-inflammatory cytokines (e.g., TNF-α, IL-6), ciglitazone being more potent. Monocytes and MDM from healthy smokers presented a significantly enhanced (4-fold and 2.5-fold, respectively) constitutive PPAR-γ expression, as compared to those from healthy non-smokers. However, ligand-induced PPAR-γ expression and inhibition of cytokine secretion were similar in healthy smokers and non-smokers. Nicotine dose-dependently enhanced PPAR-γ expression with a maximum at 10 μM, and inhibited release of pro-inflammatory cytokines; these effects were reversed by α-bungarotoxin. Nicotine and PPAR-γ agonists did not exert synergistic effects. In conclusion, monocytes and MDM from healthy smokers present a constitutively enhanced PPAR-γ expression; this effect is reproduced, to some extent, by nicotine in vitro. 2007 Elsevier Inc. All rights reserved
机译:以前的观察结果表明,过氧化物酶体增殖物激活受体-γ(PPAR-γ)是脂肪细胞分化的关键调节剂,在包括单核细胞/巨噬细胞谱系的细胞在内的多种细胞中表达。这项研究旨在量化从健康吸烟者和非吸烟者分离的单核细胞和单核细胞衍生的巨噬细胞(MDM)中组成型和配体诱导的PPAR-γ表达,并评估尼古丁的可能直接作用。通过蛋白质印迹法检测PPAR-γ蛋白,并通过计算PPAR-γ与β-肌动蛋白表达之间的比率进行定量。用酶联免疫测定试剂盒测量细胞因子的释放。在人单核细胞中检测到组成型PPAR-γ蛋白,其表达随向MDM的分化而上调。内源性配体15-脱氧-delta12,14-前列腺素J2和合成的激动剂西格列酮增强了PPAR-γ的表达,前者在低微摩尔浓度下也有效。两种激动剂均显着抑制促炎细胞因子(例如,TNF-α,IL-6)的基础分泌,西格列酮更有效。与健康非吸烟者相比,健康吸烟者的单核细胞和MDM组成型PPAR-γ表达显着增强(分别为4倍和2.5倍)。然而,在健康吸烟者和非吸烟者中,配体诱导的PPAR-γ表达和细胞因子分泌的抑制作用相似。尼古丁剂量依赖性地提高PPAR-γ的表达,最大值为10μM,并抑制促炎性细胞因子的释放;这些作用被α-真菌毒素所逆转。尼古丁和PPAR-γ激动剂没有发挥协同作用。总之,健康吸烟者的单核细胞和MDM表现为PPAR-γ表达的组成型增强。尼古丁在体外可在某种程度上重现这种作用。 2007 Elsevier Inc.保留所有权利

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号